Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 167-172

  Kappler, Matthias ^a   Taubert, Helge ^a   Bartel, Frank ^a   Blümke, Karen ^a   Panian, Matti ^a   Schmidt, Hannelore ^a   Dunst, Jürgen ^a   Bache, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Caspases; p53; Radiosensitivity; Small interfering RNA; Soft tissue sarcoma; Survivin

Indexed keywords

BIRC5 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 7; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN P53; SMALL INTERFERING RNA; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; SARCOMA; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASE 7; CASPASES; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENE SILENCING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RADIATION TOLERANCE; RNA, SMALL INTERFERING; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 21644488884     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.167     Document Type: Article

References (35)

1. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997. (Pubitemid 27353455)
2. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46-54, 2003.
3. Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M: Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277: 3247-3257, 2002. (Pubitemid 34953189)
4. Mirza A, McGuirk M, Hockenberry TN, et al: Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21: 2613-2622, 2002. (Pubitemid 34478319)
5. Zhou M, Gu L, Li F, Zhu Y, Woods WG and Findley HW: DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303: 124-131, 2002.
6. Marusawa H, Matsuzawa S, Welsh K, et al: HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22: 2729-2740, 2003. (Pubitemid 36712369)
7. Taubert H, Meye A and Wurl P: Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res 56: 4134-4136, 1996. (Pubitemid 26305004)
8. Kappler M, Kotzsch M, Bartel F, et al: Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res 9: 1098-1104, 2003. (Pubitemid 36323717)
9. Kappler M, Kohler T, Kampf C, et al: Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 95: 360-363, 2001. (Pubitemid 33015105)
10. Rodel C, Haas J, Groth A, Grabenbauer GG, Sauer R and Rodel F: Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys 55: 1341-1347, 2003. (Pubitemid 36338302)
11. Asanuma K, Moriai R, Yajima T, et al: Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91: 1204-1209, 2000.
12. Pennati M, Binda M, Colella G, et al: Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. J Invest Dermatol 120: 648-654, 2003. (Pubitemid 36344009)
13. Montgomery MK, Xu S and Fire A: RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 95: 15502-15507, 1998. (Pubitemid 29018728)
14. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001. (Pubitemid 32494397)
15. Kappler M, Bache M, Bartel F, et al: Knock-down of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 11: 186-193, 2004. (Pubitemid 38280521)
16. Bache M, Dunst J, Wurl P, et al: G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines. Anticancer Res 19: 1827-1832, 1999. (Pubitemid 29392744)
17. Taubert H, Schmidt H, Wurl P, et al: Morphological and molecular characterization of an undifferentiated soft tissue sarcoma cell line and derivative clones. Int J Oncol 11: 521-526, 1997. (Pubitemid 27364284)
18. Bache M, Würl P, Dietzel M, et al: Two human sarcoma cell lines with different p53 gene status in their response on radiation. Int J Oncol 11: 993-997, 1997. (Pubitemid 27439405)
19. Beltrami E, Plescia J, Wilkinson JC, Duckett CS and Altieri DC: Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J Biol Chem 279: 2077-2084, 2004. (Pubitemid 38084480)
20. Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T and Altieri DC: Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 9: 2683-2692, 2003. (Pubitemid 36842114)
21. Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A and Watanabe N: A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 93: 1057-1062, 2002. (Pubitemid 35154273)
22. Shankar SL, Mani S, O'Guin KN, Kandimalla ER, Agrawal S and Shafit-Zagardo B: Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem 79: 426-436, 2001. (Pubitemid 32988959)
23. Conway EM, Pollefeyt S, Steiner-Mosonyi M, et al: Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 123: 619-631, 2002. (Pubitemid 34827205)
24. Tamm I, Wang Y, Sausville E, et al: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320, 1998. (Pubitemid 28551107)
25. Li F, Ambrosini G, Chu EY, et al: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584, 1998. (Pubitemid 28563719)
26. Ambrosini G, Adida C, Sirugo G and Altieri DC: Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273: 11177-11182, 1998. (Pubitemid 28204967)
27. Shin S, Sung BJ, Cho YS, et al: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40: 1117-1123, 2001. (Pubitemid 32108606)
28. Banks DP, Plescia J, Altieri DC, et al: Survivin does not inhibit caspase-3 activity. Blood 96: 4002-4003, 2000.
29. Pruschy M, Rocha S, Zaugg K, et al: Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases. Int J Radiat Oncol Biol Phys 49: 561-567, 2001. (Pubitemid 32120257)
30. Kallio MJ, Nieminen M and Eriksson JE: Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J 15: 2721-2723, 2001.
31. Williams NS, Gaynor RB, Scoggin S, et al: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003. (Pubitemid 36323695)
32. Lens SM, Wolthuis RM, Klompmaker R, et al: Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J 22: 2934-2947, 2003. (Pubitemid 36758615)
33. Chen J, Wu W, Tahir SK, et al: Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2: 235-241, 2000. (Pubitemid 30346079)
34. Lu B, Mu Y, Cao C, et al: Survivin as a therapeutic for radiation sensitization in lung cancer. Cancer Res 8: 2840-2845, 2004. (Pubitemid 38500623)
35. Cao C, Mu Y, Hallahan DE and Lu B: XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 42: 7047-7052, 2004. (Pubitemid 39319166)